Yi Ching Yau - 07 Jun 2022 Form 4 Insider Report for ChemoCentryx, Inc.

Role
SVP, Finance & Acctg Officer
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
07 Jun 2022
Net transactions value
$0
Form type
4
Filing time
08 Jun 2022, 18:33:46 UTC
Previous filing
08 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCXI Stock Option (right to buy) Award +65,000 65,000 07 Jun 2022 Common Stock 65,000 $25.19 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on June 7, 2022, and 25% of the total number of shares of common stock subject to the option vests on June 6, 2023, and 1/48th of the total number of shares of common stock subject to the option vests monthly thereafter, subject to the Reporting Person's continued service to the Company on each such vesting date.
F2 Not applicable.